Department of Neurology, Dongzhimen Hospital/Institute of Brain and Cognitive Disorders, Beijing University of Chinese Medicine, Beijing, China.
2 developments in the corpus
Following this puts new work involving it at the top of your briefing, with a note saying why it is there. Links are taken from the source record, never inferred.
Preclinical discovery and optimization study with in vitro, xenograft, and animal toxicology data, but no human clinical evidence; Phase 1 trial is only stated as 'underway' with no results reported.